Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 8 of 120 for:    Polycystic Kidney Disease

Lanreotide In Polycystic Kidney Disease Study (LIPS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Assistance Publique - Hôpitaux de Paris
Sponsor:
Collaborator:
IPSEN pharmaceutical company, Boulogne-Billancourt, France
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT02127437
First received: April 2, 2014
Last updated: August 25, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2019
  Estimated Primary Completion Date: October 2018 (Final data collection date for primary outcome measure)